Profusa PFSA
NASDAQ PFSA
$7.57 -6.00 (-44.22%)
At close: Aug 20, 2026 · 4:00 PM EDT

Profusa (PFSA) Deferred Taxes (2023 - 2024)

Profusa (PFSA) posted quarterly Deferred Taxes of $13661.0 for Q1 2024, up 138.38% year-over-year from $5730.8 in Q2 2023, and up 200.0% quarter-over-quarter from -$13661.0 in Q4 2023.

Profusa (PFSA) Deferred Taxes (2023 - 2024) Analysis & Trends

Profusa's Deferred Taxes history runs 2 years deep, the most recent figure standing at $13661.0 for Q1 2024.

  • In Q1 2024, Deferred Taxes rose 138.38% year-over-year to $13661.0; the TTM figure through Dec 2024 stood at $13661.0 (down 41.32% YoY), while the FY2024 annual figure was $13661.0, down 41.32% from the prior year.
  • Deferred Taxes for Q1 2024 stood at $13661.0, up from -$13661.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $72537.0 in Q2 2023, with the low at -$35597.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 107.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -8.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 17.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -181.30 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -300,000.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 235.96 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 600,000.00
10 Profusa 129,730.48 -245,269.52 - -

Historic Data

Download Data
DateValue
Mar 31, 2024 13,661.00
Dec 31, 2023 -13,661.00
Jun 30, 2023 72,537.00
Mar 31, 2023 -35,597.00